There have been two major recent developments in the ongoing national struggle over the state regulation of pharmacy benefit managers (PBMs).
Celltrion's biosimilar Vegzelma (bevacizumab), used to treat metastatic colorectal and breast cancer, has secured ...
Cigna’s $100 million investment to support a new AI-powered pharmacy program and Peak Rock Capital's purchase of Asembia may ...
The videos announcing the changes were AI-generated, and some of the alleged measures on the interstate were not actually new ...
Zacks Investment Research on MSN

Here's why Cigna (CI) is a strong value stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
The strongest employee advocacy programs don’t start with templates or schedules, but with a workplace people genuinely want ...
OS 27’s new Trust Insights feature flags suspicious behavior during calls, texts and payments to help stop scams before they ...
With Hollywood and European stars and directors from around the globe descending on the Czech festival every year, THR looks ...
A group representing thousands of pharmacies has filed an antitrust suit against Prime Therapeutics, alleging that the company colluded with rival Express Scripts to fix prices. The lawsuit was filed ...